NIHR support for medtech research

The NIHR supports medtech research through commissioning and funding research projects and programmes. Through the innovation pathway, NIHR supports the development of medical devices and diagnostics. Companies can access these resources at any stage in their clinical development process.


Screen Shot 2016-07-20 at 16.45.06


The NIHR infrastructure 


BRCs and BRUs


NIHR Biomedical Research Centres (BRCs) and Units (BRUs) are based in the country’s leading hospitals and university partnerships. They conduct translational research to transform scientific breakthroughs into life-saving treatments for patients. NIHR BRCs and BRUs:





The NIHR supports 19 Clinical Research Facilities (CRFs) across the country, providing specialist clinical research staff who carry out commercial and non-commercial experimental medicine studies. NIHR CRFs:





NIHR runs eight Healthcare Technologies Co-operatives (HTCs) across the country. The HTCs address clinical areas of themes of high morbidity and unmet need for NHS patients and healthcare technology users which have not benefited from a high degree of innovation to date. The HTCs are:





The Diagnostic Evidence Co-operatives (DECs) are focused on in vitro diagnostic devices. These are centres of expertise that support the generation of evidence on commercially available in vitro diagnostic devices (IVDs). This is necessary for the NHS and IVD manufacturers to enable patients to access the most appropriate treatments more quickly and to help the NHS make the best use of its resources. NIHR DECs are:





The NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) focus on applied health research and are working with the NHS on implementation of new interventions and treatments. They are:





The NIHR Horizon Scanning Research and Intelligence Centre (HSRIC) provides advance notice to health service policy makers and research funders of selected new and emerging health technologies that may require additional research or evaluation, consideration of clinical and cost impact, or modification of clinical guidance. The nIHR HSRIC:


Contact us for more information on NIHR and funding opportunities.